FONDAZIONE GIOVANNI LORENZINI GIOVANNI LORENZINI MEDICAL FOUNDATION MILAN, ITALY HOUSTON, USA NAMS THE NORTH AMERICAN MENOPAUSE SOCIETY
5th INTERNATIONAL SYMPOSIUM ON WOMEN’S HEALTH AND MENOPAUSE NEW FINDINGS, NEW STRATEGIES, IMPROVED QUALITY OF LIFE
Florence, Italy April 21-24, 2004
PALAZZO DEI CONGRESSI
PIAZZA ADUA, 1 FLORENCE, ITALY
FINAL PROGRAM
Ministero della Salute
National Heart. INTERNATIONAL Lung and Blood ATHEROSCLEROSIS SOCIETY NIH. USA Fondazione italiana per il cuore 5th International Symposium on WOMEN’S HEALTH AND MENOPAUSE NEW FINDINGS, NEW STRATEGIES, IMPROVED QUALITY OF LIFE
Florence, Italy – April 21-24, 2004
CHAIRPERSONS P.G. Crosignani (I), R.A. Lobo (USA), R. Paoletti (I)
SCIENTIFIC SECRETARY S. Belcredito (I)
INTERNATIONAL ADVISORY BOARD B. Alder (UK), T. Aso (J), G. Assmann (D), E. Barrett-Connor (USA), E-E. Baulieu (F), M.H. Birkhäuser (CH), M.L. Brandi (I), L. Brinton (USA), H. Burger (AUS), C. Campagnoli (I), L. Cardozo (UK), C. Christiansen (DK), A. Collins (S), P. Collins (UK), P.D. Delmas (F), L. Dennerstein (AUS), O. Etingin (USA), M.L. Foegh (USA), S. Franceschi (S), U.J. Gaspard (B), M.M. Gelfand (CDN), A.R. Genazzani (I), S. Guaschino (I), J.-Å. Gustafsson (S), W.R. Harlan (USA), R.J. Hegyeli (USA), E. Hemminki (SF), V.W. Henderson (USA), S.L. Hendrix (USA), M. Hunter (UK), E.V. Jensen (USA), J.A. Kanis (UK), P. Kenemans (NL), W.-W. Kim (K), B.E.K. Klein (USA), C. La Vecchia (I), Cl. Lenfant (USA), R. Lindsay (USA), D.W. Losordo (USA), A. Maggi (I), L. Martini (I), J.A. McGowan (USA), A. McTiernan (USA), M.E. Mendelsohn (USA), D.R. Mishell Jr. (USA), M. Motta (I), F. Naftolin (USA), M. Neves-e Castro (P), M. Notelovitz (USA), B.W. O'Malley (USA), A. Pines (IL), V.W. Pinn (USA), D.W. Purdie (UK), S.M. Resnick (USA), B.L. Riggs (USA), G. Rosano (I), H. Rozenbaum (F), G. Samsioe (S), R.M. Sarrel (USA), K. Schenck-Gustafsson (S), G. Serra (I), S. Sherman (USA), B.B. Sherwin (CDN), E. Simpson (AUS), P. Sismondi (I), S.O. Skouby (DK), L. Speroff (USA), M.J. Stampfer (USA), J.C. Stevenson (UK), D.W. Sturdee (UK), W.H. Utian (USA), E. Vegeto (I), M.P. Vessey (UK), N.K. Wenger (USA), N.F. Woods (USA)
Scientific-Organizing Secretariats:
Main Secretariat Office Branch Secretariat Office MENO 2004 MENO 2004 FONDAZIONE GIOVANNI LORENZINI GIOVANNI LORENZINI MEDICAL SCIENCE FOUNDATION MEDICAL FOUNDATION Via A. Appiani 7 6535 Fannin, M.S. A-601 20121 MILAN (ITALY) HOUSTON, TEXAS 77030 (USA) Phone: (+39) 02 29.00.62.67 Phone: (+1-713) 797.0401 Telefax: (+39) 02 29.00.70.18 Telefax: (+1-713) 796.8853 E-mail: [email protected] E-mail: [email protected] Home page: http://www.lorenzinifoundation.org
I JOINTLY SPONSORED BY International Atherosclerosis Society (IAS) National Heart, Lung, and Blood Institute (NHLBI/NIH) Fondazione Giovanni Lorenzini Medical Sciences Foundation Giovanni Lorenzini Medical Foundation Italian Heart Foundation
UNDER THE AUSPICES OF British Menopause Society Dutch Menopause Society European Menopause and Andropause Society (EMAS) German Society of Menopause Hungarian Menopause Society International Menopause Society (IMS) Israeli Menopause Society Italian Menopause Society Italian Society of Geriatric Gynecology (SIGITE) Italian Society of Gynecology and Obstetrics (SIGO) Office of Research on Women’s Health/NIH (ORWH/NIH) Polish Menopause and Andropause Society Portuguese Menopause Society Romanian Medical Menopause Association Slovak Society for Menopause and Andropause Slovene Society for Menopause Spanish Menopause Society Swiss Menopause Society
IN COOPERATION WITH The North American Menopause Society (NAMS)
II GENERAL INFORMATION
PLACE AND DATE OF THE SYMPOSIUM The Symposium takes place in Florence (Italy) at the Palazzo dei Congressi (Piazza Adua, 1 – Florence - Phone: +39 055 49721) on April 21-24, 2004.
CONGRESS BUILDINGS PALAZZO DEI CONGRESSI Room A Room B Room C Registration Exhibition Poster Display
SECRETARIAT DESK The following services are available at the secretariat desk: • registration (pre-registered participants and on-site registrations) • secretariat • information • incoming mail and messages • lost and found
Opening Hours Tuesday, April 20: 5.00 pm – 7.00 pm Wednesday, April 21: 7.45 am – 7.00 pm Thursday, April 22: 7.45 am – 7.00 pm Friday, April 23: 7.45 am – 7.00 pm Saturday, April 24: 7.45 am – 6.00 pm
REGISTRATION Only registered participants may attend the scientific sessions and the social events offered by the Symposium. The late enrollment fee (from April 11 and on site) will be charged even if the registration form (without payment) was received before that date.
The registration fees for the Symposium are as follows: (all amounts given in EUROS)
from April 11 and on site Participants € 550 Accompanying Persons € 150 Students* € 300
(V.A.T. included)
(*) Student rate registrations are available to those who demonstrate their student position by presenting a state- ment from the Head of their Department or Institute.
III All participants, nurses, and students are entitled to: • attend all Scientific Sessions • attend the Opening of the Symposium • receive Final Program and Abstract Book • Coffee Breaks • Welcome Reception
All accompanying persons regularly enrolled are entitled to: • Welcome Reception • ticket for the Visit to the Churches in “Oltrarno”
FOR ITALIAN PARTICIPANTS ONLY All the Italian participants with the VAT/IVA number must indicate this number (and the corresponding address) in the registration form (DPR 633/72). The regular invoice for the registration will be sent only to those who have indicated the fiscal code and/or the IVA number (compulsory if available) of the actual payer.
BADGES The official name badge must be worn for admission to all sessions and other activities of the Symposium. Badges will show different colours: BLUE Organizers RED Invited Speakers and Chairpersons WHITE Participants GREEN Students YELLOW Accompanying Persons BANK The branch of the Cassa di Risparmio di Firenze located on the ground floor of the Centro Affari (in front of the Palazzo dei Congressi, across the garden) will operate a counter for participants. Opening hours: 8.20 - 13.20 and 14.35 - 15.35; Saturday and Sunday: closed. CASH - BAR Cash-bar is available for the participants in the Palazzo dei Congressi. CERTIFICATE OF ATTENDANCE Certificates of Attendance will be available on request at the end of the Symposium at the Registration Desk. The request form is enclosed in the Symposium envelope.
CME CREDITS (ECM for Italian Participants only) CME Credits for Italian Participants only (ECM) have been applied for from the Italian Ministry of Health for selected sessions. The list of these sessions can be found in the ECM envelope to be requested by intere- sted Italian participants at the registration desk. See also the time table on pages XII-XIII. The badge of the Italian participants requesting the Credits must be checked by the hostess through the bar code registra- tion system when entering and leaving the congress room through the ECM dedicated door. Please check with the ECM desk at the registration desk for more informations. COFFEE BREAKS Coffee Breaks will be offered to all registered participants at the Palazzo dei Congressi from Wednesday morning, April 21 until Saturday morning, April 24. ELECTRICITY The electrical power is 220 volts, 50 Hz. E-MAIL SERVICE E-mail service will be available in the exhibition area at the Palazzo dei Congressi to allow the attendees to send and receive messages during the Symposium. The address is: [email protected] To receive e-mails during the Symposium, the sender of the message must fill in the subject/object field with the complete name of the recipient (Symposium participant).
IV INSURANCE Registration for the Congress implies that the participant agrees that neither the Scientific Organizing Committee nor the Fondazione Giovanni Lorenzini assume any liability or responsibility whatsoever. The Congress participants are requested to make their own arrangements for medical, travel, and personal insurance. The Scientific Organizing Committee cannot assume liability for changes in the program due to external circumstances.
INTERNET Home page for the Menopause 2004 Congress is located at: http://www.lorenzinifoundation.org
LUNCHES A list of nearby restaurants and cafeterias is included in the Symposium envelope for lunch/dinner options.
MAIL AND FAX During the Symposium, mail may be addressed to the participants: MENO 2004 – FONDAZIONE GIOVANNI LORENZINI MEDICAL SCIENCE FOUNDATION c/o Palazzo dei Congressi – Piazza Adua 1 – Florence (Italy) – Telefax: +39 055 4973301
OFFICIAL LANGUAGE The official language of the Symposium is English. No simultaneous translation is provided.
POST OFFICE The main post office is located in Via Pellicceria. Opening hours: 8.15 - 18.30 (Saturday: 8.15 - 12.30; - Sunday: closed).
PRESS REGISTRATION Working press from newspapers, magazines, radio and television stations, and medical publications will be registered free, provided that they can officially demonstrate their position.
SCIENTIFIC EXHIBITION During the Symposium an exhibition of technical instruments and products is held in the meeting area net to the registrations and to the main conference room.
TELEPHONES Telephone calls can be made from the pay telephones (phone cards) placed in the Palazzo dei Congressi. Cards can be purchased in the bars and from the door keeper at the Palazzo dei Congressi.
TRANSPORTATION Pisa Galileo Galilei and Florence Peretola airports are served by several international airlines. Pisa airport is about 90 km from Florence, but a shuttle train operates every hour between the airport and the main railway station in Florence. The trip lasts approximately 65 minutes. Florence airport is only 4 km from the centre of town. Bus and taxi transportation is available between the airport and downtown Florence. An airport taxi will charge approximately Euros 18 for the journey to the city centre. Rome Fiumicino international airport is connected by train with Florence railway station. For further infor- mation and updated train schedule please contact NEWTOURS desk. The main railway station in Florence is S. Maria Novella near the Congress Centre. Intercity trains connect Florence with Milan (approximately 2h 45) and Rome (approximately 2h).
TRAVEL AGENCY, TOURS AND SIGHTSEEING NEWTOURS desk is located in the Secretariat area. The staff will be happy to organize sightseeing tours, make reservations, and arrange other necessary transportation. The opening hours are: Tuesday, April 20: 5.00 pm – 7.00 pm Wednesday, April 21: 7.45 am – 7.00 pm Thursday, April 22: 7.45 am – 7.00 pm Friday, April 23: 7.45 am – 7.00 pm Saturday, April 24: 7.45 am – 6.00 pm
V SCIENTIFIC PROGRAM INFORMATION
The Scientific Program will include Plenary Sessions, Workshops, Round Tables, Sponsored Symposia and Poster Sessions for contributed papers. RULES FOR CHAIRPERSONS Every effort must be made to adhere to the time-table of the scientific sessions. Chairpersons are asked to interrupt speakers if they exceed their allocated time. NOTICE TO ALL SPEAKERS (Slide Centers, Projection Facilities,...) Presentations and discussions must be given in English. POWER POINT PRESENTATIONS: Power Point presentations will be accommodated with an LCD- panel projection system. Speakers are kindly requested to bring No. 2 copies (one for back up) of the electronic support containing their slides. They can preview their electronic devices for antivirus scan- ning and check the slide files in the slide center at least 1 hour before the start of the session or during the breaks. If speakers use their own computer, it must be given to the room technician at least one hour before the start of the session or during the breaks. For any other service please contact directly the Secretariat desk.
POSTER PRESENTATION
POSTER NUMBER: the program number corresponding to your abstract will already be posted at the top of the board. The authors must use the board with this number. MOUNTING AND the mounting and the removal of the posters must be done by the authors according REMOVAL POSTERS: to the following schedule: Mounting: Tuesday, April 20 from 5.00 pm to 7.00 pm and Wednesday, April 21 from 8.00 am to 9.00 am Removal: Saturday, April 24 from 2.00 pm to 4.00 pm
The organizers are not responsible for any item, including posters, left in the room.
POSTER DISPLAY: is for the duration of the Symposium
POSTER Poster discussion is scheduled on Thursday, April 22 and Friday, April 23 DISCUSSION: from 12.30 pm to 2.00 pm.
Note: - "Poster assistants" will be present for any information or help the authors may need. - Facilities for slide projection are not available at the site of poster presentation. - Photocopies made from a reduction of your poster and any additional material may be distributed by the author(s) during the poster discussion.
LAST-MINUTE COMMUNICATIONS A notice-board will be placed in the Symposium area, where any last-minute program changes and other essential information will be posted. Participants are kindly asked to check this board frequently.
VI SOCIAL PROGRAM
The official name badge will be required for all the Social Events, irrespective of whether or not a charge is made. No admittance to the events will be possible without presentation of the name badge. The ticket will be required for the social event for registered accompanying persons (Churches in Oltrarno). Please note that the ticket is valid for 1 person only.
SOCIAL EVENTS (for registered participants and accompanying persons)
Wednesday, April 21 2004 (evening) Event No. 1 (complimentary) h. 19.30 WELCOME RECEPTION at the PALAZZO BORGHESE (Via Ghibellina, 110 - Florence)
SOCIAL EVENT (for registered accompanying persons only)
Thursday, April 22, 2004 (morning - half day) Event No. 2 (complimentary)
CHURCHES IN “OLTRARNO” (Tour by foot - Lunch not included) Departure time: 8.45 am Meeting point: Social Program Desk in the Secretariat Area.
Visit to Santa Felicita Church, near the Ponte Vecchio, housing one the greatest masterpieces of Mannerist art: the drammatic “Deposition from the Cross” by Pontormo. Proceed on to Santo Spirito Church, built by Brunelleschi, the greatest Florentine Reinassance architect. And lastly, visit the Carmine Church, housing Masaccio’s frescoes in the newly restored Brancacci Chapel. By Foot
For further details please refer to the corresponding ticket included in the Symposium envelope.
VII IN GRATEFUL APPRECIATION
The Organizing Committee is grateful to all the contributors that have generously supported the Symposium:
PLATINUM LEVEL Novo Nordisk
◆
GOLDEN LEVEL Lilly Wyeth Pharmaceuticals
◆
SILVER LEVEL Procter & Gamble Pharmaceuticals Merck Sharp & Dohme Italia
◆
BRONZE LEVEL Bracco S.p.A.
Exhibitors: Bracco S.p.A. Lilly Novo Nordisk Rottapharm Sigma-Tau Valderma Viatris Wyeth Pharmaceuticals
The Organizing Committee gratefully acknowledges Aboca S.p.A. and Ferrero S.p.A. for offering their products during the coffee breaks.
VIII 5th International Symposium on WOMEN’S HEALTH AND MENOPAUSE NEW FINDINGS, NEW STRATEGIES, IMPROVED QUALITY OF LIFE
Florence, Italy – April 21-24, 2004
EXHIBITION 13 12 11 4 1 12 POSTERS 5 9 10 11 1 6 8 7 1
10 Coffee breaks Coffee 7 6 9 5 3 4 2 1
EXHIBITORS
N. 1 Lorenzini Foundation - Internet point N. 2 North American Society of Menopause (NAMS) N. 3 Lilly N. 4 Novo Nordisk N. 5, 6, 7, 8 Wyeth Pharmaceuticals N. 9 Sigma-Tau N. 10 Valderma N. 11 Rottapharm N. 12 Viatris N. 13 Bracco S.p.A.
IX
TIME TABLE 5th International Symposium on WOMEN’S HEALTH AND MENOPAUSE NEW FINDINGS, NEW STRATEGIES, IMPROVED QUALITY OF LIFE
Florence, Italy – April 21-24, 2004
LECTURES, SYMPOSIA, WORKSHOPS MORNING
WEDNESDAY, THURSDAY, FRIDAY, SATURDAY, APRIL 21 APRIL 22 APRIL 23 APRIL 24
Opening Plenary Session (ECM) Plenary Session (ECM) Plenary Session (ECM) 9.00 – 9.30 HORMONES, CENTRAL NERVOUS CANCER p. 1 INFLAMMATION AND SYSTEM 8.30 – 10.00 MENOPAUSE 8.30 – 10.00 p. 23 Plenary Session (ECM) 8.30 – 10.00 p. 15 OPENING LECTURE p. 6 Plenary Session (ECM) XXX Lorenzini Annual Lecture Plenary Session (ECM) QUALITY OF LIFE 9.30 – 10.30 Plenary Session (ECM) BONE AND JOINTS 10.30 – 12.00 p. 1 PHARMACOLOGY OF 10.30 – 12.30 p. 24 MENOPAUSE: p. 16 PERSPECTIVES Plenary Session (ECM) 10.30 – 12.30
ROOM A CARDIOVASCULAR SYSTEM p. 7 AND THE METABOLIC SYNDROME 11.00 – 12.30 p. 1
Workshop THE WOMEN’S HEALTH INITIATIVE HORMONE TRIALS: IMPLICATIONS FOR MENOPAUSAL AND POSTMENOPAUSAL WOMEN 10.00-11.35 p. 8 ROOM B
For Italian participants, only CONSIGLIO DIRETTIVO SIGITE 12.00 – 12.30 p. 21 ROOM C
XII 5th International Symposium on WOMEN’S HEALTH AND MENOPAUSE NEW FINDINGS, NEW STRATEGIES, IMPROVED QUALITY OF LIFE
Florence, Italy – April 21-24, 2004
LECTURES, SYMPOSIA, WORKSHOPS AFTERNOON
WEDNESDAY, THURSDAY, FRIDAY, SATURDAY, APRIL 21 APRIL 22 APRIL 23 APRIL 24
Workshop Sponsored Symposium Sponsored Symposium Round Table CLINICAL MARKERS AND (ECM) (ECM) THE FUTURE OF RISK FACTORS FOR CVD BONE QUALITY IS A MAJOR BALANCING EFFICACY AND MENOPAUSE: AN 14.00-15.35 DETERMINANT OF SAFETY FOR INTERNATIONAL VIEW p. 2 ANTIFRACTURE EFFICACY INDIVIDUALIZED HRT 14.00-15.30 OF BONE ACTIVE AGENTS 14.00 – 15.30 p. 25 Workshop IN POSTMENOPAUSAL p. 17 DIABETES AND WOMEN WITH MENOPAUSE OSTEOPOROSIS Workshop 16.00-17.25 14.00 – 15.30 QUALITY OF LIFE AND p. 3 p. 9 SOCIOCULTURAL ASPECTS OF MENOPAUSE ROOM A Workshop 16.00-18.05 BONE AND JOINTS: p. 18 CLINICAL PHARMACOLOGY 16.00-17.05 p. 10
Sponsored Symposium Workshop Workshop Workshop (ECM) RESPONSES TO ESTROGENS AND CANCER THE NEW DIRECTION IN ENDOCRINE CHANGES COGNITION 14.00-15.55 HORMONE THERAPY… 14.00-15.15 16.00-17.05 p. 26 CUSTOMIZING LOW DOSE p. 11 p. 19 THERAPY 14.00 – 15.00 Workshop Progetto Menopausa Italia p. 4 CARDIOVASCULAR (PMI) (session in Italian) DISEASE SINTOMATOLOGIA Workshop 16.00-17.25 CLIMATERICA IN POST- NEW TREATMENTS p. 12 MENOPAUSA 16.00-17.40 17.10-18.35 ROOM B p. 5 Workshop p. 20 PHYSICAL EXERCISE AND DRUGS PREVENTING CVD 17.30-18.05 p. 13
Workshop Forum SIM-SIGITE INTERPRETING (session in Italian) EPIDEMIOLOGICAL ATTUALITÀ SULL’HRT REPORTS 12.30 – 14.00 16.00-17.10 p. 21 p. 14 CONSIGLIO DIRETTIVO SIM 14.00 – 14.30 p. 21
Workshop
ROOM C OSTEOARTHRITIS AND OTHER BONE DISEASES RELATED TO MENOPAUSE 16.00-17.35 p. 22
XIII 5th International Symposium on WOMEN’S HEALTH AND MENOPAUSE NEW FINDINGS, NEW STRATEGIES, IMPROVED QUALITY OF LIFE
Florence, Italy – April 21-24, 2004
POSTERS PALAZZO DEI CONGRESSI
POSTER DISPLAY: Poster Session 1 for the duration of the MENOPAUSE: DETERMINANTS AND Symposium SYMPTOMS (1-15) p. 27-28 POSTER DISCUSSION: Poster Session 2 Thursday, April 22 CARDIOVASCULAR DISEASE (16-27) and p. 29-30
Friday, April 23 Poster Session 3 from 12.30 pm to 2.00 pm CANCER (28-37) p. 31-32
Poster Session 4 COGNITION AND MOOD DISORDERS (38-42) p. 33
Poster Session 5 DRUGS AND TREATMENT STRATEGIES (43-54) p. 34-35
Poster Session 6 PHYTOESTROGENS (55-67) p. 36-37
Poster Session 7 QUALITY OF LIFE, LIFESTYLE AND SOCIO-CULTURAL ASPECTS OF MENOPAUSE (68-82) p. 38-39
XIV Scientific Program
(THE AUTHOR IN BOLD FACE IS THE PRESENTING AUTHOR) PARTICIPANTS ARE REQUESTED TO REFRAIN FROM SMOKING IN THE MEETING AREA
ADMISSION TO THE SCIENTIFIC SESSIONS RESERVED ONLY FOR PARTICIPANTS WEARING THE MEETING BADGE 9.00 - 12.30 WEDNESDAY, April 21 ROOM A
9.00 - 9.30 OPENING REMARKS
Paoletti R. (University of Milan, Italy) Armosino M.T. (Italian Ministry of the Economy and Finance, Rome, Italy) Crosignani P.G. (University of Milan, Italy) Lobo R.A. (Columbia University, New York, NY, USA) WEDNESDAY
hour: abstract bk. page ref.:
9.30 – 10.30 Opening Lecture of the Symposium XXX LORENZINI ANNUAL LECTURE
Chairpersons: Paoletti R. (Milan, Italy) Crosignani P.G. (Milan, Italy) Genazzani A.R. (Pisa, Italy)
HORMONES AND BREAST CANCER RISK AFTER THE WOMEN’S HEALTH 1 INITIATIVE TRIAL OF ESTROGEN PLUS PROGESTIN Collins J. (Hamilton, ON, CANADA)
10.30 Break
Plenary Session CARDIOVASCULAR SYSTEM AND THE METABOLIC SYNDROME
Chairpersons: Mendelsohn M.E. (Boston, MA, USA) Paoletti R. (Milan, Italy)
11.00 PHYSIOLOGICAL ROLE OF ESTROGEN AND ESTROGEN RECEPTORS IN THE 1 CARDIOVASCULAR SYSTEM: 2004 UPDATE Mendelsohn M.E. (Boston, MA, USA)
11.30 DO GENES DETERMINE RISK AND BENEFITS OF HRT? NEW DATA FROM HERS 1 AND OTHER TRIALS Herrington D.M. (Winston-Salem, NC, USA)
12.00 DIABETES AND THE METABOLIC SYNDROME IN WOMEN 1 Zambon A. (Padua, Italy)
12.30 End of the Session
12.30 - 14.00 VISIT TO THE POSTERS
1 14.00 - 15.35 WEDNESDAY, April 21 ROOM A
Workshop CLINICAL MARKERS AND RISK FACTORS FOR CARDIOVASCULAR DISEASE
Chairpersons: Pines A. (Tel Aviv, Israel) Zambon A. (Padua, Italy)
hour: abstract bk. page ref.:
14.00 CARDIOVASCULAR PROTECTION: IS POSTMENOPAUSAL HORMONE 2 THERAPY NO LONGER AN OPTION? van der Mooren M.J. (Amsterdam, The Netherlands)
14.20 OXIDATIVE STRESS CONTRIBUTES TO REDUCED LARGE ELASTIC 2 ARTERY COMPLIANCE IN ESTROGEN-DEFICIENT POSTMENOPAUSAL WOMEN Moreau K.L., Plum A.E., Gavin K., Seals D.R. (Boulder and Denver, CO, USA)
14.35 HEART DISEASE RISK DETERMINES MENOPAUSAL AGE RATHER 2 THAN REVERSE Kok H.S., van Asselt K.M., van der Schouw Y.T., van der Tweel I., Peeters P.H.M., Wilson P.W.F., Pearson P.L., Grobbee D.E. (Utrecht, The Netherlands and Boston, MA, USA)
14.50 DIVERGENT EFFECTS OF SYNTHETIC PROGESTINS ON ENDOTHELIAL 2 NITRIC OXIDE SYNTHASE Simoncini T., Mannella P., Fornari L., Varone G., Caruso A., Genazzani A.R. (Pisa, Italy)
15.05 OPPOSITE MODULATION OF INFLAMMATORY ENZYMES BY ESTROGEN 3 AND RESVERATROL IN VASCULAR SMOOTH MUSCLE CELLS Cignarella A., Minici C., Bolego C., Pinna C., Crippa M., Puglisi L. (Milan, Italy)
15.20 HIGH MW FGF2, BUT NOT LOW MW FGF2 NOR VEGF, MEDIATES THE EFFECT 3 OF ESTRADIOL ON REENDOTHELIALIZATION Garmy-Susini B., Delmas E., Gourdy P., Zhou M., Brouchet L., Mugniot A., Bayard F., Prats A.C., Doetschman T., Prats H., Arnal J.F. (Toulouse, France and Cincinnati, OH, USA)
15.35 End of the Session
15.35 - 16.00 Break
2 16.00 - 17.25 WEDNESDAY, April 21 ROOM A
Workshop DIABETES AND MENOPAUSE
Chairpersons: Skouby S.O. (Copenhagen, Denmark)
Cagnacci A. (Modena, Italy) WEDNESDAY
hour: abstract bk. page ref.:
16.00 HORMONE THERAPY IN MENOPAUSAL DIABETIC WOMEN? 3 Skouby S.O. (Copenhagen, Denmark)
16.20 MODIFICATION OF GLUCOSE METABOLISM BY POSTMENOPAUSAL 3 THERAPIES Cagnacci A., Renzi A., Baldassari F., Alessandrini C., Pirillo D., Caretto S., Cannoletta M., Volpe A. (Modena, Italy)
16.40 ALTERED ESTROGEN RECEPTOR EXPRESSION IN RAT AORTA IS 4 INVOLVED IN DIABETIC VASCULAR DYSFUNCTION Minici C., Cignarella A., Brusadelli A., Bolego C., Maggi A., Puglisi L. (Milan, Italy)
16.55 RELATIONSHIP BETWEEN HOMA AND METABOLIC MARKERS IN 4 PERI-AND POSTMENOPAUSAL WOMEN Bergmann S., Mix C. (Dresden, Germany)
17.10 SEX HORMONES AND RESTING ENERGY EXPENDITURE 4 Day D.S., Gozansky W.S., VanPelt R.E., Schwartz R.S., Kohrt W.M. (Boulder and Denver, CO, USA)
17.25 End of the Session
3 14.00 - 15.00 WEDNESDAY, April 21 ROOM B
Sponsored Symposium THE NEW DIRECTION IN HORMONE THERAPY… LOW DOSE CUSTOMIZING THERAPY
Chairperson: Crosignani P.G. (Milan, Italy)
hour: abstract bk. page ref.:
14.00 APPROPRIATE USE OF LOW DOSE HORMONE THERAPY FOR 4 MENOPAUSAL SYMPTOMS: WOMEN’S HOPE STUDY Pickar J.H. (Philadelphia, PA, USA)
14.30 ENDOMETRIAL AND SKELETAL EFFECTS OF LOW DOSE HORMONE 5 THERAPY: WOMEN’S HOPE STUDY Lobo R.A. (New York, NY, USA)
15.00 End of the Session
15.00 - 16.00 Break
4 16.00 - 17.40 WEDNESDAY, April 21 ROOM B
Workshop NEW TREATMENTS
Chairpersons: Utian W.H. (Cleveland, OH, USA)
Neves-e-Castro M. (Lisboa, Portugal) WEDNESDAY
hour: abstract bk. page ref.:
16.00 MINING THE COMPLEXITIES OF ESTROGEN AND PROGESTERONE 5 ACTION FOR PHARMACEUTICAL OPPORTUNITIES McDonnell D.P. (Durham, NC, USA)
16.20 RISK-BENEFIT PROFILE FOR RALOXIFENE: 4-YEAR DATA FROM THE 5 MULTIPLE OUTCOMES OF RALOXIFENE EVALUATION (MORE) RANDOMIZED TRIAL Barrett-Connor E., Cauley J.A., Kulkarni P.M., Sashegyi A., Cox D.A., Geiger M.J. (San Diego, CA, Pittsburgh, PA, and Indianapolis, IN, USA)
16.40 RALOXIFENE'S MODULATION OF BONE HOMEOSTASIS: EFFECTS ON 5 HUMAN OSTEOBLASTS IN VITRO Brama M., Moreschini O., Scandurra R., Falcone S., Agnusdei D., Spera G., Migliaccio S. (Rome and Florence, Italy)
16.55 HMR 3339, A NOVEL SERM, REDUCES TOTAL CHOLESTEROL, 6 LDL-CHOLESTEROL AND HOMOCYSTEINE. A 14-WEEK, RANDOMIZED, PLACEBO-CONTROLLED STUDY IN HEALTHY POSTMENOPAUSAL WOMEN Vogelvang T.E., Mijatovic V., Kenemans P., Teerlink T., van der Mooren M.J. (Amsterdam, The Netherlands)
17.10 THE HERBAL ALTERNATIVES FOR MENOPAUSE STUDY: FACTORS ASSOCIATED 6 WITH SELF REPORTED SEVERITY OF BASELINE VASOMOTOR SYMPTOMS Newton K.M., Reed S.D., Grothaus L., Ehrlich K., Guiltinan J., LaCroix A.Z. (Seattle and Kenmore, WA, USA)
17.25 MENOPAUSE FORMULA, A PHYTOESTROGEN CONTAINING SUPPLEMENT, 6 REDUCES HOT FLUSHES. A 12-WEEK RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY IN HEALTHY EARLY POSTMENOPAUSAL WOMEN Verhoeven M.O., van der Mooren M.J., van de Weijer P.H.M., Verdegem P.J.E., van der Burgt L.M.J., Kenemans P. (Amsterdam, Apeldoorn, and Wageningen, The Netherlands)
17.40 End of the Session
5 8.30 - 10.00 THURSDAY, April 22 ROOM A
Plenary Session HORMONES, INFLAMMATION, AND MENOPAUSE
Chairpersons: Barrett-Connor E. (San Diego, CA, USA) Cuzzocrea S. (Messina, Italy)
hour: abstract bk. page ref.:
8.30 ESTROGENS AND GLIAL CELLS 6 Garcia-Segura L.M., Veiga S., Garcia-Ovejero D., Azcoitia I. (Madrid, Spain)
9.00 ESTROGENS AND INFLAMMATION 7 Cuzzocrea S. (Messina, Italy)
9.30 THE ROLE OF INFLAMMATION IN CARDIOVASCULAR DISEASE AND 7 EFFECTS OF HORMONE REPLACEMENT Cushman M. (Colchester, VT, USA)
10.00 End of the Session
10.00 - 10.30 Break
6 12.30 –14.00 12.30 20 ANDROGENSFORWOMEN 12.00 13 PHYTOESTROGENS,REPLACEMENTFORHORMONE 11.30 10 SELECTIVEESTROGENRECEPTORMODULATORS INTHEMANAGEMENT 11.00 03 CLASSICALANDNONESTROGENRECEPTORACTION 10.30 hour: 10.30 -12.30 PHARMACOLOGY OFMENOPAUSE: PERSPECTIVES Lobo R.A. VISIT TOTHEPOSTERSANDPOSTERDISCUSSION End oftheSession Wuttke W. THERAPY? Delmas P.D. OF POSTMENOPAUSAL WOMEN Ciana P., MussiP., (New York, NY, USA) (Goettingen, Germany) (Lyon, France) Chairpersons: Maggi A. (Milan, Italy) THURSDAY, April22 Plenary Session Lobo R.A. Maggi A. 7 (Milan, Italy) (New York, NY, USA) abstract bk. ROOM A page ref.: 8 8 7 7
THURSDAY 10.00 - 11.35 THURSDAY, April 22 ROOM B
WORKSHOP THE WOMEN’S HEALTH INITIATIVE HORMONE TRIALS: IMPLICATIONS FOR MENOPAUSAL AND POSTMENOPAUSAL WOMEN
Chairperson: Pinn V.W. (Bethesda, MD, USA)
hour: abstract bk. page ref.:
10.00 OPENING REMARKS – Pinn V.W. (Bethesda, MD, USA)
10.05 PRIMARY RESULTS FROM THE WHI TRIAL OF CONJUGATED EQUINE 8 ESTROGEN ONLY (CEE) AND CONTRASTS WITH THE WHI CEE+MPA TRIAL Stefanick M.L. (Stanford, CA, USA)
10.30 IMPLICATIONS OF WHI FINDINGS FOR RECENTLY MENOPAUSAL WOMEN 8 Rossouw J.E. (Bethesda, MD, USA)
10.55 WHAT WHI CAN AND CANNOT SAY ABOUT QUALITY OF LIFE 9 Gass M. (Cincinnati, OH, USA)
11.20 QUESTION AND ANSWER PERIOD WHI PANEL –
11.35 End of the Session
8 15.30 -16.00 15.30 43 CLINICALUSEOFRALOXIFENEINPOSTMENOPAUSAL WOMEN 14.30 40 BONEQUALITY: FROMBENCHTO BEDSIDE 14.00 hour: 50 RALOXIFENE:SHORT ANDLONG-TERMCHOICEFOROSTEOPOROSIS 15.00 14.00 -15.30 ANTIFRACTURE EFFICACYOFBONEACTIVEAGENTSIN POSTMENOPAUSAL WOMENWITHOSTEOPOROSIS Break End oftheSession Brandi M.L. PREVENTION ANDTREATMENT Delmas P.D. Bouxsein M.L. BONE QUALITYISAMAJORDETERMINANTOF (Florence, Italy) (Lyon, France) (Boston, MA,USA) Chairpersons: Sponsored Symposium THURSDAY, April22 Adami S. Agnusdei D. 9 (Verona, Italy) (Florence, Italy) abstract bk. ROOM A page ref.: 9 9 9
THURSDAY 16.00 - 17.05 THURSDAY, April 22 ROOM A
Workshop BONE AND JOINTS: CLINICAL PHARMACOLOGY
Chairpersons: Brandi M.L. (Florence, Italy) Omodei U. (Brescia, Italy)
hour: abstract bk. page ref.:
16.00 BONE SPARING COMPOUNDS 10 Adami S. (Verona, Italy)
16.20 EFFECT OF TIBOLONE ON BIOCHEMICAL MARKERS OF BONE TURNOVER 10 IN LATE POSTMENOPAUSAL WOMEN Kamenov Z., Todorova M., Christov V., Nikolov I. (Sofia, Bulgaria)
16.35 OUR CLINICAL EXPERIENCE USING ONCE-MONTHLY NERIDRONATE 10 IN POSTMENOPAUSAL OSTEOPOROTIC WOMEN Grua D., Ragusa O.L.F., Rosiello P. (Venaria Reale, Italy)
16.50 COMPLIANCE OF POSTMENOPAUSAL OSTEOPOROTIC PATIENTS WITH 10 DIFFERENT TREATMENT REGIMENS Segal E., Gurevich B., Ish-Shalom S. (Haifa, Israel)
17.05 End of the Session
10 15.15 -16.00 15.15 THEEFFECTOFASOY-RICH DIETONUROGENITAL ATROPHY: A PEL 15.00 SKINAGING:ANATOMICAL, FUNCTIONAL ANDCLINICALASPECTS 14.40 14.20 CHANGESINTHEHYPOTHALAMO-PITUITARY-OVARIAN AXISDURING 14.00 hour: 14.00 -15.15 Break End oftheSession (Bangkok,Thailand andInje,Korea) Manonai J. RANDOMIZED, CROSSOVERTRIAL Meschia M. Caputo R. Australia,andStockholm,Sweden) Melbourne, Burger H. THE MENOPAUSAL TRANSITION VIC FLOORFUNCTION RESPONSES TOENDOCRINECHANGES enrti . oeto . adrnBM (Claytonand , DennersteinL.,RobertsonD.,Landgren B.M. (Milan, Italy) , SongchitsomboonS.,ChandaK.,HongJ.H.,KomindrS. , Pifarotti P. Chairpersons: (Magenta andMilan,Italy) THURSDAY, April22 Workshop Meschia M. Balmforth J. 11 (Magenta, Italy) (London, UK) abstract bk. ROOM B page ref.: 11 11 11 11
THURSDAY 16.00 - 17.25 THURSDAY, April 22 ROOM B
Workshop CARDIOVASCULAR DISEASE
Chairpersons: Hegyeli R. (Bethesda, MD, USA) Melis G.B. (Cagliari, Italy)
hour: abstract bk. page ref.:
16.00 ACUTE CORONARY SYNDROMES IN WOMEN 12 Wenger N.K. (Atlanta, GA, USA)
16.20 HYPERTENSION: PECULIAR FEATURES IN POSTMENOPAUSAL WOMEN 12 Modena M.G., Origliani G., Coppi F., Rossi R. (Modena, Italy)
16.40 REPRODUCIBILITY OF THE MEASUREMENT OF THE ANKLE-ARM INDEX 12 IN POSTMENOPAUSAL WOMEN; INFLUENCE OF LOCATION AND DEVICE Atsma F., Bartelink M.E.L., Grobbee D.E., van der Schouw Y.T. (Utrecht, The Netherlands)
16.55 A COMPARATIVE STUDY OF 2mg ESTRADIOL/DYDROGESTERONE AND 12 2mg ESTRADIOL/TRIMEGESTONE ON FACTORS INVOLVED IN THE VENOUS HAEMOSTATIC BALANCE Norris L.A., Brosnan J.F., Bonnar J., Conard J., Kluft C., Meijer P., Hellgren M. (Dublin, Ireland, Paris, France, Leiden, The Netherlands, and Goteborg, Sweden)
17.10 EFFECT OF LONG-TERM HORMONE REPLACEMENT THERAPY ON 13 COAGULATION FACTOR VII: A RANDOMIZED CONTROLLED STUDY IN HEALTHY POSTMENOPAUSAL WOMEN Madsen J.S., Bladbjerg E.M., Gram J., Hermann A.P., Brixen K., Rejnmark L., Jespersen J., Kristensen S.R. (Odense, Esbjerg, and Aarhus, Denmark)
17.25 End of the Session
12 18.05 THEIMPACT OFEXERCISEWITHORWITHOUTHORMONEREPLACEMENT EXERCISEANDAGING 17.50 17.30 hour: 17.30 -18.05 End oftheSession Shamsuddin K.(KualaLampur, Malaysia) Adeeb N. THERAPY (HRT) ONCARDIOVASCULAR RISKINPERIMENOPAUSE Baggio G. PHYSICAL EXERCISEANDDRUGPREVENTING , OngF.B.,Teh R.,MohamedA.L.,NawawiH.M.,SeriS.S.,NoorainiM.Y., , Nardi C.(Padua,Italy) Chairpersons: CARDIOVASCULAR DISEASE THURSDAY, April22 Gaspard U.J. Serra G.B. Workshop 13 (Rome, Italy) (Liege, Belgium) abstract bk. ROOM B page ref.: 13 13
THURSDAY 16.00 - 17.10 THURSDAY, April 22 ROOM C
Workshop INTERPRETING EPIDEMIOLOGICAL REPORTS
Chairpersons: Rossouw J.E. (Bethesda, MD, USA) Parazzini F. (Milan, Italy)
hour: abstract bk. page ref.:
16.00 HORMONES AND CANCER RISK: INTERPRETING EPIDEMIOLOGICAL 13 RESULTS Brinton L.A. (Bethesda, MD, USA)
16.20 INTERPRETING EPIDEMIOLOGICAL RESULTS IN DIFFERENT POPULATIONS: 14 THE EXAMPLE OF PROGETTO MENOPAUSA ITALIA (PMI) Parazzini F., Donati Sarti C., Gruppo di Studio Progetto Menopausa Italia (Milan and Perugia, Italy)
16.40 AGE AT MENOPAUSE, MORTALITY AND LIFE EXPECTANCY 14 Ossewaarde M.E., Bots M.L., Verbeek A.L.M., Peeters P.H.M., van der Graaf Y., Grobbee D.E., van der Schouw Y.T. (Utrecht and Nijmegen, The Netherlands)
16.55 ALLELIC VARIANTS IN CYTOKINE GENES AMONG AFRICAN-AMERICAN 14 AND WHITE WOMEN Ness R.B., Haggerty C.L., Ferrell R. (Pittsburgh, PA, USA)
17.10 End of the Session
14 .0MENOPAUSE, MEMORY, ANDDEMENTIA 9.00 10.00 -10.30 10.00 SLEEPDISORDERSINWOMEN-DOESMENOPAUSE HAVE A 9.30 .0ERß-AMULTIFUNCTIONAL REGULATOR OFWOMEN’SHEALTH 8.30 hour: 8.30 -12.30 Break End oftheSession Polo-Kantola P. SPECIAL IMPACT Henderson V.W. Gustafsson J.-Å. Chairpersons: (Turku, Finland) CENTRAL NERVOUS SYSTEM CENTRAL NERVOUS (Little Rock,AR,USA) (Huddinge, Sweden) Henderson V.W. Gustafsson J-Å. Plenary Session FRIDAY, April23 15 (Little Rock,AR,USA) (Huddinge, Sweden) abstract bk. ROOM A page ref.: 15 15 14
FRIDAY 10.30 - 12.30 FRIDAY, April 23 ROOM A
Plenary Session BONE AND JOINTS
Chairpersons: Lindsay R. (New York, NY, USA) Brandi M.L. (Florence, Italy)
hour: abstract bk. page ref.:
10.30 THE CLINICAL PHARMACOLOGY OF OSTEOPOROSIS IN 15 POSTMENOPAUSAL WOMEN Lindsay R. (New York, NY, USA)
11.00 DISSOCIATION OF SKELETAL FROM REPRODUCTIVE EFFECTS OF SEX 15 STEROIDS BY ACTIVATION OF NONGENOTROPIC SIGNALS: NOVEL INSIGHTS INTO BONE ANABOLISM AND A SAFER HRT Manolagas S.C. (Little Rock, AR, USA)
11.30 SEX HORMONES IN THE REGULATION OF BONE AND CARTILAGE 16 METABOLISM: AN OLD PARADIGM AND A NEW CHALLENGE Christgau S., Hoegh-Andersen P., Delaissé J.M., Christiansen C. (Herlev and Ballerup, Denmark)
12.00 GENETICS OF OSTEOPOROSIS 16 Brandi M.L. (Florence, Italy)
12.30 End of the Session
12.30 - 14.00 VISIT TO THE POSTERS AND POSTER DISCUSSION
16 15.30 -16.00 15.30 VAGINAL ERT: THETHERAPEUTICSTANDARD FORUROGENITAL AGING 15.20 VAGINAL ERT AFTERBREASTCANCER 15.00 14.40 HRT: IMPROVINGQUALITYOFLIFEIMPACT OFHRT ONBONE, HRT: DOESTHEPROGESTOGENMAKEDIFFERENCE? 14.20 14.00 hour: 14.00 -15.30 BALANCING EFFICACYANDSAFETYFORINDIVIDUALIZEDHRT Break End oftheSession General Discussion S Graziottin A. Gambacciani M. POSTMENOPAUSAL WOMEN CLIMACTERIC SYMPTOMSANDBODYWEIGHTINEARLY Stevenson J.C. ˇ imunic ´ V. (Zagreb, Croatia) (Milan, Italy) (London, UK) (Pisa, Italy) Chairperson: Sponsored Symposium FRIDAY, April23 Genazzani A.R. 17 (Pisa, Italy) abstract bk. ROOM A page ref.: 17 17 16 16
FRIDAY 16.00 - 18.05 FRIDAY, April 23 ROOM A
Workshop QUALITY OF LIFE AND SOCIOCULTURAL ASPECTS OF MENOPAUSE
Chairpersons: Dennerstein L. (Melbourne, VIC, Australia) Motta M. (Milan, Italy)
hour: abstract bk. page ref.:
16.00 INTERMITTENT LOW DOSE HRT TO MAINTAIN QUALITY OF LIFE 17 Gelfand M.M. (Montreal, Canada)
16.20 MENOPAUSE, SURGICAL MENOPAUSE AND SEXUAL FUNCTIONING 17 Dennerstein L., Koochaki P., Graziottin A., Rodenberg C. (Melbourne, Australia, Milan, Italy and Cincinnati, OH, USA)
16.40 THE ROLE OF ANDROGENS IN FEMALE SEXUAL FUNCTIONING 18 Genazzani A.R. (Pisa, Italy)
17.00 DO DEPRESSIVE AND ANXIOUS SYMPTOMS INCREASE DURING OR AFTER 18 THE MENOPAUSAL TRANSITION? RESULTS FROM THE FIRST FIVE YEARS OF THE STUDY OF WOMEN'S HEALTH ACROSS THE NATION (SWAN) Bromberger J.T., Schott L., Matthews K.M., Brockwell S., Gold E., Kravitz H., Randolph J., Sowers M. (Pittsburgh, PA, Davis, CA, Chicago, IL, Ann Arbor, MI, USA)
17.15 PSYCHOSOCIAL BEHAVIORAL AND HEALTH FACTORS RELATED TO 18 MENOPAUSE SYMPTOMATOLOGY Collins A. (Stockholm, Sweden)
17.35 SEASONAL VARIATIONS OF OXIDATIVE STRESS PARAMETERS IN WOMEN 18 Adelwoehrer N.E., Lindschinger M., Wonisch W., Birkmayer J. (Laßnitzhöhe, Graz, and Vienna, Austria)
17.50 MEETING THE NEEDS OF WOMEN FOR HEALTHCARE INFORMATION 19 Snoxall S., Stevenson J. (Bucks, Uk)
18.05 End of the Session
18 62 EFFECTSOFESTROGENPLUSPROGESTINONPROGRESSION TO 16.20 65 ER 16.50 63 ESTROGENACTIVITYINMICROGLIAASAPOTENTIAL 16.35 60 HORMONETHERAPYANDCOGNITIONINWHISCA:THEWOMEN’SHEALTH 16.00 hour: 17.05 16.00 -17.05 Etteri S., PHARMACOLOGICAL TARGET FORADTHERAPY (Winston-Salem, NC,USA) Legault C. HEALTH INITIATIVE MEMORY STUDY(WHIMS) DEMENTIA INPOSTMENOPAUSAL WOMEN:RESULTS FROMTHEWOMEN'S Resnick S.M. INITIATIVE STUDYOFCOGNITIVEAGING End oftheSession Belcredito S. ON MICROGLIA α MEDIATES THEANTI-INFLAMMATORY ACTIVITYOF17ß-ESTRADIOL Vegeto E. , ShumakerS.A.,RappS.R.,WHIMSStudyGroup Chairpersons: , EtteriS.,GueriniRoccoA.,GhislettiMaggiVegeto E.(Milan,Italy) (Baltimore, MD,USA) ESTROGEN ANDCOGNITION , GhislettiS.,Belcredito S.,MaggiA.(Milan,Italy) Resnick S.M. Vegeto E. FRIDAY, April23 Workshop 19 (Milan, Italy) (Baltimore, MD,USA) abstract bk. ROOM B page ref.: 19 19 19 20
FRIDAY 17.10 - 18.35 FRIDAY, April 23 ROOM B
Sessione Programma Menopausa Italia SINTOMATOLOGIA CLIMATERICA IN POST-MENOPAUSA DATI DEL PMI Sessione in italiano senza traduzione (Session in Italian, translation not provided)
Moderatori: Becorpi A.M. (Firenze) Omodei U. (Brescia) hour: abstract bk. page ref.:
17.10 INTRODUZIONE –
17.20 SINTOMATOLOGIA VASOMOTORIA Quaranta S. (Milano)
17.35 ATTACCHI DI PANICO – Fiorillo F. (Napoli)
17.50 TURBE DEL SONNO – Donati Sarti C. (Perugia)
18.05 SINDROME DEPRESSIVA – Chirico C. (Cento-Ferrara)
18.20 SESSUALITÀ – Graziottin A. (Milano)
18.35 DISCUSSIONE – CHIUSURA DEI LAVORI
20 12.00 - 14.30 FRIDAY, April 23 ROOM C
Sessione SIM-SIGITE ATTUALITA’ SULL’HRT
Sessione in italiano senza traduzione (Session in Italian, translation not provided)
hour: abstract bk. page ref.:
12.00-12.30 CONSIGLIO DIRETTIVO SIGITE –
12.30 INTRODUZIONE AL TEMA: Becorpi A. (Firenze) - Guaschino S. (Trieste)
DISCUSSANTS: – Campagnoli C. (Torino) Melis G.B. (Cagliari) Omodei U. (Brescia) Serra G.B. (Roma)
14.00-14.30 CONSIGLIO DIRETTIVO SIM FRIDAY
21 16.00 - 17.35 FRIDAY, April 23 ROOM C
Workshop OSTEOARTHRITIS AND OTHER BONE DISEASES RELATED TO MENOPAUSE
Chairpersons: Christiansen C. (Copenhagen, Denmark) Scarselli G. (Florence, Italy)
hour: abstract bk. page ref.:
16.00 OSTEOPOROSIS IN PREMENOPAUSAL WOMEN 20 Guaschino S., Grimaldi E., Sartore A., Inglese S., Lanza P. (Trieste, Italy)
16.20 SELF REPORTED ARTHRITIS AND THE MENOPAUSE 20 Szoeke C.E.I., Cicuttini F., Guthrie J., Dennerstein L. (Melbourne, Australia)
16.35 OSTEOPOROSIS IN POSTMENOPAUSE: EXPERIENCE OF ASL 6, VENARIA 20 Grua D., Ragusa O.L.F., Rosiello P. (Venaria Reale, Italy)
16.50 OSTEOPOROSIS AND VERTEBRAL FRACTURES INCIDENCE IN CLINICALLY 21 HEALTHY MENOPAUSAL WOMEN Pierro E., Leoni F., Trivellini C., Andreani C.L., Castaldo F. (Roma, Italy)
17.05 RISK OF LOW-ENERGY FRACTURE IN THE YEARS AFTER DISCONTINUATION 21 OF HORMONE REPLACEMENT THERAPY (HRT) Hundrup Y.A., Høidrup S., Obel E.B., Ekholm O., Davidsen M. (Copenhagen, Denmark)
17.20 ESTROGEN DEFICIENCY ALTERS TRABECULAR MICROARCHITECTURE OF 21 MANDIBLE AND TIBIA Yang J., Pham S.M., Crabbe D.L., (Philadelphia, PA, USA)
17.35 End of the Session
22 .0MENOPAUSE, HORMONETHERAPYANDBREASTCANCERRISK 9.00 10.00 -10.30 10.00 THEBIOLOGICALBASISFORDETECTIONOFEARLY STAGE 9.30 .0MOLECULARMECHANISMSOFFEMALESEXHORMONEACTION 8.30 hour: 8.30 -10.00 Break End oftheSession Fishman D. OVARIAN CANCER La Vecchia C. Weisz A. ON PROLIFERATION Chairpersons: (Naples, Italy) (Chicago, IL,USA) (Milan, Italy) Kenemans P. Sismondi P. SATURDAY, April24 Plenary Session CANCER (Turin, Italy) 23 (Amsterdam, TheNetherlands) abstract bk. ROOM A page ref.: 22 22 21
SATURDAY 10.30 - 12.00 SATURDAY, April 24 ROOM A
Plenary Session QUALITY OF LIFE
Chairpersons: Birkhaeuser M. (Bern, Switzerland) Guaschino S. (Trieste, Italy)
hour: abstract bk. page ref.:
10.30 QUALITY OF LIFE THROUGH AND BEYOND MENOPAUSE-DEFINITION 22 AND EVALUATION Utian W.H. (Cleveland, OH, USA)
11.00 EXERCISE EFFECTS ON TOTAL BODY FAT, INTRA-ABDOMINAL FAT, 22 INSULIN, LEPTIN, AND THE METABOLIC SYNDROME IN MENOPAUSE McTiernan A. (Seattle, WA, USA)
11.30 OESTROGENS AND THE LOWER URINARY TRACT 23 Balmforth J. (London, UK)
12.00 End of the Session
12.30 - 14.00 VISIT TO THE POSTERS
24 15.30 hour: 14.00-15.30 14.00 -15.30 THE FUTUREOFMENOPAUSE: ANINTERNATIONAL VIEW End oftheSession General Discussion Lobo R.A. WHERE WESTAND? Genazzani A.R. ENDOCRINOLOGY (ISGE) THE POINTOFVIEWOF:INTERNATIONAL SOCIETYOF GYNECOLOGICAL Pines A. THE POINTOFVIEWOF:INTERNATIONAL MENOPAUSE SOCIETY(IMS) Skouby S.O. SOCIETY (EMAS) THE POINTOFVIEWOF:EUROPEANMENOPAUSE ANDANDROPAUSE Utian W.H. (NAMS) THE POINTOFVIEWOF:NORTHAMERICAN SOCIETYOFMENOPAUSE Pinn V.W. HEALTH-NATIONAL INSTITUTESOFHEALTH (ORWH-NIH) THE POINTOFVIEWOF:OFFICERESEARCHONWOMEN’S (Tel Aviv, Israel) (Bethesda, MD,USA) (New York, NY, USA) (Cleveland, OH,USA) (Copenhagen, Denmark) Chairpersons: (Pisa, Italy) SATURDAY, April24 Paoletti R. Crosignani P.G. Lobo R.A. Round Table 25 (New York, NY, USA) (Milan, Italy) (Milan, Italy) abstract bk. ROOM A page ref.: – – – – – –
SATURDAY 14.00 - 15.55 SATURDAY, April 24 ROOM B
Workshop CANCER
Chairpersons: Fernandez E. (Barcelona, Spain) De Bortoli F. (Turin, Italy)
hour: abstract bk. page ref.:
14.00 HORMONE REPLACEMENT THERAPY (HRT) AND COLORECTAL CANCER: 23 NEW EVIDENCE FOR AN UNSPECTED FINDING Fernández E. (Barcelona, Spain)
14.20 MOLECULAR CHARACTERIZATION OF BREAST CANCER AGGRESSIVENESS 23 De Bortoli M. (Turin, Italy)
14.40 COMBINED ADMINISTRATION OF INDOMETHACIN, ANASTROZOLE AND 23 VINORELBINE EXERT ANTIANGIOGENIC, ANTIMITOTIC AND ANTIAROMATASE ACTION AGAINST INVASIVE DUCTAL CA (IDC) METASTASIZED TO AXILLARY LYMPH NODES OF A POSTMENOPAUSAL PATIENT CHARACTERIZED BY OVEREXPRESSION OF HER-2/NEU, COX-2, RAS, BCL-2 AND ER Giannios J., Michailakis E. (Athens, Greece)
14.55 THE D327N VARIANT OF HUMAN SEX HORMONE-BINDING GLOBULIN (SHBG) 24 IS LINKED TO BREAST CANCER GOOD PROGNOSIS Fortunati N., Biglia N., Cozzarella M., Catalano M.G., Bocuzzi G., Sismondi P., Frairia R. (Turin, Italy)
15.10 MICROARRAY AND PROTEOMICS ANALYSES OF TIBOLONE, 24 MEDROXIPROGESTERONE ACETATE AND 17ß-ESTRADIOL IN BREAST CANCER CELLS IN VITRO Mirkin S., Wong B.C., Corica A., Archer D.F. (Norfolk, VA, USA)
15.25 ENDOMETRIOSIS AND ENDOMETRIOSIS-RELATED MORBIDITY IN A 24 LARGE COHORT Ness R.B., Modugno F.M., Allen G.O. (Pittsburg, PA, USA)
15.40 ENDOMETRIAL CANCER IN POSTMENOPAUSAL WOMEN 24 Bakhidze E.V., Maximov S.J., Chepic O.F., Belyaeva A.V. (St. Petersburg, Russia)
15.55 End of the Session
26 Palazzo dei Congressi WEDNESDAY, April 21 - SATURDAY, April 24 1-15
POSTERS
POSTER DISPLAY: for the duration of the Symposium (from April 21 to April 24)
POSTER DISCUSSION: one of the authors will be available at the poster on: Thursday April 22 and Friday April
23 from 12.30 pm to 2.00 pm WEDNESDAY
Poster Session 1 MENOPAUSE: DETERMINANTS AND SYMPTOMS
Poster board abstract bk. no.: page ref.:
1. INHIBIN A, INHIBIN B, PRO-ALPHAC AND ACTIVIN A-VALID MARKERS FOR 25 OVARIAN AGING? Seufert R., Neubert S., Schaffrath M., Pollow K., Kölbl H. (Mainz, Germany)
2. OSTEOPROTEGERIN AND RANKL: WHAT IS THEIR ROLE IN THE OSTEOPORO- 25 SIS MANAGEMENT AND DIAGNOSIS (POST-MENOPAUSAL)? THURSDAY D’Amore M., D’Amore S., Minenna G. (Bari, Italy)
3. GENETIC MECHANISMS IN PREMATURE OVARIAN FAILURE: IMPLICATION OF X 25 CHROMOSOME Vladareanu R., Tutunaru D. (Bucharest, Romania)
4. PROBABILITY OF DEVELOPING PREMATURE OVARIAN FAILURE (POF) AT DIF- 25 FERENT CUMULATIVE DOSES OF INTRAVENOUS CYCLOPHOSPHAMIDE (IV CYC) THERAPY Cravioto M.C., Mestanza-Peralta M., Boeck L., Sánchez-Guerrero J. (Mexico City, Mexico)
5. THE ATP-SENSITIVE POTASSIUM CHANNEL OPENER ZM226600 IMPROVES 26 MICTURITION PARAMETERS IN FEMALE RATS WITH PARTIAL URETHRA FRIDAY OBSTRUCTION Pinna C., Sanvito P., Bolego C., Cignarella A., Minici C., Puglisi L. (Milan, Italy)
6. UROGENITAL ATROPHY AND URINARY TRACT INFECTIONS 26 Hakim A., Falconier A., Gonzalez C., Sucari A., Bigozzi M.A. (Buenos Aires, Argentina)
7. COMBINED VAGINAL ESTRIOL AND SYSTEMIC ALPHA ADRENERGIC AGONIST 26 THERAPY - EARLY EFFECTS ON UROGENITAL COMPLAINTS IN POSTMENO- PAUSAL WOMEN WITH NON INSULIN DEPENDENT DIABETES MELLITUS NIDDM Fica S., Gheorghisan-Galateanu A., Virtej I., Barbu C., Vladareanu R. (Bucharest, Romania)
8. LOWER URINARY TRACT SYMPTOMS AMONG MALAYSIAN WOMEN 45 YEARS 26 AND ABOVE AND ITS IMPACT ON THEIR QUALITY OF LIFE Tayib S., Sufian S.S., Jamil M.A. (Kuala Lumpur, Malaysia) SATURDAY 9. URINARY INFECTION ASSOCIATED WITH PREGNANCY 27 Ra˘ca˘N., Gazdac R., Olimid D. (Craiova, Romania)
27 10. CLINICAL EFFECTS OF FINASTERIDE, A 5-α-REDUCTASE INHIBITOR, IN POST- 27 MENOPAUSAL WOMEN WITH HAIR LOSS Ciotta L., Marletta E., Morana M., De Pasquale R. (Catania, Italy)
11. AGING HANDS - THE SECOND COSMETIC TARGET ON SENIORS 27 Marincea E., Stuparu E., Stoenescu M.R., Ciochirca M.A. (Bucharest, Romania)
12. CONSIDERATIONS CONCERNING THE DIAGNOSIS OF DYSFUNCTIONAL UTE- 27 RINE BLEEDINGS IN PREMENOPAUSE Gheorman V. (Craiova, Romania)
13. FUNCTIONAL HYPOTALAMIC AMENORRHOEA: A SEXUOLOGICAL EVALUATION 28 Mainini G., De Franciscis P., Quirino L., Rotondi M. (Naples, Italy)
14. SUBCLINICAL HYPOTHYROIDISM AMONG SUBJECTIVE AND OBJECTIVE 28 SYMPTOMS IN MENOPAUSE TRANSITION: PREVALENCE AND INCIDENCE Ciotta L., Marletta E., Morana M., Scollo A. (Catania, Italy)
15. MENOPAUSAL SYMPTOMS; NOT ALWAYS REFLECT BODY STATUS 28 Atis A., Kesim M.D., Isik S., Aydin Y., Emre E. (Istanbul, Turkey)
28 Palazzo dei Congressi WEDNESDAY, April 21 - SATURDAY, April 24 16-27
POSTER DISPLAY: for the duration of the Symposium (from April 21 to April 24)
POSTER DISCUSSION: one of the authors will be available at the poster on: Thursday April 22 and Friday April 23 from 12.30 pm to 2.00 pm
Poster Session 2 WEDNESDAY CARDIOVASCULAR DISEASE
Poster board abstract bk. no.: page ref.:
16. USEFULNESS OF EXPERIMENTAL MODELS TO UNDERSTAND THE EFFECTS 28 OF OESTROGENS ON ATHEROSCLEROSIS Arnal J.F., Gourdy P., Garmy-Susini B., Delmas E., Laurell H., Filipe C., Bayard F. (Toulouse, France)
17. THE EFFECT OF CHRONIC ESTROGEN DEFICIENCY ON KEY DETERMINANTS 29 OF LV MASS Crabbe D.L., Pham S.M., Yang J., Houser S.R. (Philadelphia, PA, USA) THURSDAY
18. THE ESTROGEN REGULATED MYELOPEROXIDASE ENZYME'S INHIBITORS 29 AFFECT AORTIC INTIMA-MEDIA THICKNESS IN NEW-ZEALAND RABBITS Bekesi G., Illyes Gy., Kakucs R., Szombath D., Szekacs B., Feher J. (Budapest, Hungary)
19. HYDROPHOBIC DERIVATIVES OF ESTRADIOL INHIBIT HIGH DENSITY LIPO- 29 PROTEIN OXIDATION Höckerstedt A., Jauhiainen M., Tikkanen M.J. (Helsinki, Finland)
20. NO EFFECT OF LONG-TERM HORMONE REPLACEMENT THERAPY ON FIBRI- 29 NOGEN LEVEL IN SMOKING WOMEN: A RANDOMIZED CONTROLLED STUDY Madsen J.S., Kristensen S.R., De Maat M.P.M., Abrahamsen B., Rejnmark L., Brixen K., Gram J., Christensen K., Jespersen J. (Odense, Aarhus, Esbjerg, Denmark) FRIDAY 21. CHANGES IN THE LIPID STATUS AND HAEMOSTASIS SYSTEM DURING HOR- 30 MONE REPLACE Tasic L., Dunjic R., Vasiljevic M., Dzinic M., Jovanovic T. (Belgrade, Serbia and Montenegro)
22. DOSE-DEPENDENT RISES IN SERUM C-REACTIVE PROTEIN TO INCREASING 30 DOSES OF ORAL BUT NOT TO TRANSDERMAL ESTRADIOL: EVIDENCE OF NO ROLE OF PROGESTIN AND A HISTORY OF INTRAHEPATIC CHOLESTASIS OF PREGNANCY Ropponen A., Aittomaki K., Tikkanen M., Ylikorkala O. (Helsinki, Finland)
23. THE INFLUENCE OF NORETHISTERONE ACETATE ON INFLAMMATORY 30 MARKERS IN POSTMENOPAUSAL WOMEN RECEIVING ESTRADIOL Zegura B., Guzic-Salobir B., Sebestjen M., Keber I., Koenig W. (Maribor and Ljubljana, Slovenia; and Ulm, Germany)
24. HEMODYNAMIC AND METABOLIC CHANGES IN HYPERTENSIVE PERI- AND 30 SATURDAY POSTMENOPAUSAL WOMEN Bystrova M.M., Britov A.N., Deev A.D. (Moscow, Russia)
29 25. ISCHEMIC HEART DISEASE IN PRE-MENOPAUSE WOMEN (CLINICAL ANGIO- 31 GRAPHIC STUDY) Vardugina N.G. (Chelyabinsk, Russia)
26. HORMONE REPLACEMENT THERAPY AND ITS RELATIONSHIP TO GLUCOSE- 31 METABOLISM IN NON-DIABETIC POSTMENOPAUSAL WOMEN Panagopoulos P., Economou A., Kleinaki M., Cotsakos G., Eliades M. (Piraeus, Greece)
27. MENOPAUSE ACCELERATES OXIDATIVE STRESS IN POSTMENOPAUSAL MIDDLE 31 AGED FEMALES Vachulova A., Blazˇícˇ ek P., Lietava J. (Bratislava, Slovakia)
30 Palazzo dei Congressi WEDNESDAY, April 21 - SATURDAY, April 24 28-37
POSTER DISPLAY: for the duration of the Symposium (from April 21 to April 24)
POSTER DISCUSSION: one of the authors will be available at the poster on: Thursday April 22 and Friday April 23 from 12.30 pm to 2.00 pm
Poster Session 3 WEDNESDAY CANCER
Poster board abstract bk. no.: page ref.:
28. SEX HORMONE-BINDING GLOBULIN (SHBG) MODULATION OF ESTROGEN- 31 REGULATED GENE ESPRESSION IN BREAST CANCER Catalano M.G., Frairia R., Costantino L., Pugliese M., Bocuzzi G., Fortunati N. (Turin, Italy)
29. RELEVANCE OF THYROID DISORDERS IN BREAST CANCER 32 Appetecchia M., Barnabei A., Ferretti E., Massaro R. (Roma, Italy)
30. GENOME WIDE ANALYSIS OF DNA IN ENDOMETRIAL CANCER USING COMPA- 32 THURSDAY RATIVE GENOMIC HYBRIDISATION MICROARRAYS O’Toole S.A., Dunn E., Sheppard B.L, Smyth P., Martin C., Sheils O., O’Leary J.J., Bektic J., Klocker H. (Dublin, Ireland and Innsbruck, Austria)
31. OESTROGEN REGULATED GENE EXPRESSION IN NORMAL AND MALIGNANT 32 ENDOMETRIAL TISSUE O'Toole S.A., Dunn E., Sheppard B.L., Sheils O., O’Leary J.J., Wuttke W., Seidlova-Wuttke D. (Dublin, Ireland and Goettingen, Germany)
32. GENOME WIDE ANALYSIS OF DNA IN ENDOMETRIAL CELLS TREATED WITH 32 PHYTOESTROGENS USING COMPARATIVE GENOMIC HYBRIDISATION MICROARRAYS O'Toole S.A., Sheppard B.L., Smyth P., Martin C., Sheils O., O'Leary J.J., Spengler B., Christoffel V. (Dublin, Ireland and Neumarkt, Germany) FRIDAY
33. OVEREXPRESSION OF P53 AND P53 POLYMORPHISM IN HPV RELATED CERVI- 33 CAL CARCINOMA Sharifah N.A., Clarence K.C.H., Wong C.S., Siti Aishah M.A., Hatta A.Z., Ng P., Adeeb N. (Kuala Lumpur, Malaysia)
34. THE COMBINED TREATMENT OF LOCAL-SPREAD CERVIX CANCER BY USING 33 EMBOLIZATION AND CHEMOEMBOLIZATION Tadjibaeva U.T. , Sabirdjanova Z.R., Tadjiev H.K. (Tashkent, Uzbekistan)
35. USEFULNESS OF MORPHOLOGICAL AND DOPPLER ULTRASONOGRAPHIC 33 INDICES IN DIFFERENTIATION OF OVARIAN TUMORS IN POSTMENOPAUSAL WOMEN Szpurek D., Moszynski R., Stanek J., Szczublewski P., Sajdak S. (Poznan, Poland)
36. CLINICAL VALUE OF CA 125 AND TPS ASSESSMENT IN OVARIAN TUMORS 33 MALIGNANCY PREDICTION IN POSTMENOPAUSAL WOMEN SATURDAY Moszynski R., Szpurek D., Stanek J., Smolen A., Sajdak S. (Poznan and Lublin, Poland)
31 37. REPRODUCTIVE SCREENING STRATEGIES IN THE PERIMENOPAUSE 34 Adeeb N., Ong F.B., Ghani N.A.A., Mohamed A.L., Nawawi H.M., Seri S.S., Nooraini M.Y., Shamsuddin K. (Kuala Lumpur, Malaysia)
32 Palazzo dei Congressi WEDNESDAY, April 21 - SATURDAY, April 24 38-42
POSTER DISPLAY: for the duration of the Symposium (from April 21 to April 24)
POSTER DISCUSSION: one of the authors will be available at the poster on: Thursday April 22 and Friday April 23 from 12.30 pm to 2.00 pm
Poster Session 4 WEDNESDAY COGNITION AND MOOD DISORDERS
Poster board abstract bk. no.: page ref.:
38. INVOLVEMENT OF ESTROGENS IN THE MODULATION OF BEHAVIORAL AND 34 LOCOMOTOR RESPONSE IN RATS Lencu C.C., Orbai P., Duncea I., Gozariu L. (Cluj-Napoca, Romania)
39. EFFECT OF RALOXIFENE AND HORMONE REPLACEMENT THERAPY ON 34 SERUM MARKERS OF CHOLESTEROL METABOLISM IN HEALTHY POSTMENO- PAUSAL WOMEN Vogelvang T.E., Mijatovic V., van der Mooren M.J., Pinsdorf U.,von Bergman K., Netelenbos J.C., Lutjohann D. (Amsterdam, The Netherlands and Bonn, Germany) THURSDAY
40. THE EFFICACY OF ATYPICAL ANTI-PSYCHOTICS IN THE TREATMENT OF AGI- 34 TATION AND PSYCHOSIS IN ALZHEIMER DISEASE Stuparu E., Marincea E., Ciochirca M.A., Stoenescu M.R., Ciochirca M. (Bucharest, Romania)
41. MOOD SYMPTOMS IN POSTMENOPAUSAL WOMEN: A PRELIMINARY REPORT 35 Morawska D., Wojcicka A., Stachowicz N., Kotarski J. (Lublin, Poland)
42. THE HERBAL ALTERNATIVES FOR MENOPAUSE STUDY: THE ASSOCIATION OF 35 SLEEP DISTURBANCE AND DEPRESSION WITH DIMINISHED LIBIDO Reed S.D., Newton K.M., Grothaus L., Ehrlich K., Guiltinan J., LaCroix A.Z. (Seattle and Kenmore, WA, USA) FRIDAY SATURDAY
33 Palazzo dei Congressi WEDNESDAY, April 21 - SATURDAY, April 24 43-54
POSTER DISPLAY: for the duration of the Symposium (from April 21 to April 24)
POSTER DISCUSSION: one of the authors will be available at the poster on: Thursday April 22 and Friday April 23 from 12.30 pm to 2.00 pm
Poster Session 5 DRUGS AND TREATMENT STRATEGIES
Poster board abstract bk. no.: page ref.:
43. EFFECTS OF HMR 3339, A NOVEL SERM, ON MARKERS OF COAGULATION 35 AND FIBRINOLYSIS. A 14-WEEK RANDOMIZED, PLACEBO-CONTROLLED STUDY IN HEALTHY POSTMENOPAUSAL WOMEN Vogelvang T.E., Mijatovic V., Kenemans P., Emeis J.J., Heijst J.A., van der Mooren M.J. (Amsterdam and Leiden, The Netherlands)
44. DT56a A POTENT PHYTO-SERM FOR THE COMBINED TREATMENT OF MENO- 35 PAUSAL SYMPTOMS AND OSTEOPOROSIS Yoles I., Somjen D., Kaplan B. (Tel Aviv, Israel)
45. EARLY START OF SEQUENTIAL HORMONE REPLACEMENT THERAPY IN PERI- 36 MENOPAUSE HAS NEUTRAL OR POSITIVE EFFECTS ON METABOLIC MARKERS Fait T., Vrablik M. (Prague, Czech Republic)
46. EFFECTS OF CONTINUOUS COMBINED HORMONE REPLACEMENT THERAPY 36 AND TIBOLONE ON HAEMOSTASIS PARAMETERS Tasic L., Vasiljevic M., Dunic R., Dzinic M., Dragojevic S., Lekic D. (Belgrade, Serbia and Montenegro)
47. WEIGHT CHANGE AND ADVERSE EVENT INCIDENCE WITH A DIFFERENT COM- 36 BINED ESTRADIOL-PROGESTIN REGIMENS IN POSTMENOPAUSAL WOMEN Ciotta L., Morana M., Scollo A., Marletta E. (Catania, Italy)
48. TWO-YEAR ADHERENCE IN THE ESTONIAN POSTMENOPAUSAL HORMONE 36 THERAPY TRIAL Vorobjov S., Hovi S.-L., Veerus P., Hemminki E. (Tallinn and Tartu, Estonia; and Tampere and Helsinki, Finland)
49. PRESCRIPTION OF HORMONE REPLACEMENT THERAPY IN A MENOPAUSE 37 CLINIC AFTER WHI PUBLICATION Fiore V., Di Pace R., Rossi M., Moroni S., Daguati R., Maffioletti C., Parazzini F., Crosignani P.G. (Milan, Italy)
50. EFFECT OF HRT BASED ON TRANSDERMAL ESTRADIOL AND TRANSVAGINAL 37 PROGESTERONE ON BLOOD SERUM LIPID PROFILE Paszkowski T. (Lublin, Poland)
51. IUMPA-2: UTERINE ARTERIES FLOW VELOCIMETRY IN PATIENTS WITH HYPER- 37 PLASTIC ENDOMETRIUM AFTER INTRAUTERINE MEDROXYPROGESTERONE TREATMENT Kowalski A.J., Struzycki K., Welfel J., Suzin J. (Lodz, Poland)
34 4 UTILIZATION OFHEALTH CAREDURINGTHEFIRSTYEAROFPOSTMENOPAU- IUMPA-2: PHOTODYNAMICMETHODINDIAGNOSISOFENDOMETRIALPATHO- 54. IUMPA-2: DOPPLERFLOWINUTERINEARTERIES INWOMENWITHENDOME- 53. 52. Finland) Veerus P. SAL HORMONETHERAPY Welfel J. LOGY FIRSTANNOUNCEMENT Struzycki K. TRIAL HYPERPLASIASIMPLEX , KowalskiA.J.,StruzyckiK.,SuzinJ.(Lodz,Poland) , HoviS.L.,HemminkiE.(Tallin, EstoniaandTampere andHelsinki, , KowalskiA.J.,Welfel J.,SuzinJ.(Lodz,Poland) 35 38 38 37
SATURDAY FRIDAY THURSDAY WEDNESDAY Palazzo dei Congressi WEDNESDAY, April 21 - SATURDAY, April 24 55-67
POSTER DISPLAY: for the duration of the Symposium (from April 21 to April 24)
POSTER DISCUSSION: one of the authors will be available at the poster on: Thursday April 22 and Friday April 23 from 12.30 pm to 2.00 pm
Poster Session 6 PHYTOESTROGENS
Poster board abstract bk. no.: page ref.:
55. BIOAVAILABILITY OF ISOFLAVONE PHYTOESTROGENS FROM SOYMILK FER- 38 MENTED WITH PROBIOTIC BIFIDOBACTERIA Tsangalis D., Wilcox G., Shah N., Stojanovska L. (Melbourne, Australia)
56. EFFECT OF THE PHYTOESTROGENS ON ANTI-HEAT SHOCK PROTEIN ANTIBO- 38 DIES, NITRIC OXIDE, AND VASCULAR REACTIVITY IN MENOPAUSE Pereira I.R.O., Faludi A.A., Berolami M.C., Campos M.F., Aldrighi J.M., Abdalla D.S.P. (São Paulo, Brazil)
57. PHYTOESTROGENS AND HORMONAL REPLACEMENT THERAPY ON CHOLE- 39 STEROL OXIDES IN MENOPAUSE Pereira I.R.O., Faludi A.A., Berolami M.C., Campos M.F., Aldrighi J.M., Abdalla D.S.P. (São Paulo, Brazil)
58. EFFECTS OF ISOLATED ISOFLAVONOIDS ON LIPIDS, LIPOPROTEINS, INSULIN- 39 SENSITIVITY AND GHRELIN IN POSTMENOPAUSAL WOMEN Nikander E., Tiitinen A., Laitinen K.,Tikkanen M., Ylikorkala O. (Helsinki and Espoo, Finland)
59. EFFECTS OF MENOPAUSE FORMULA, A PHYTOESTROGEN-CONTAINING SUP- 39 PLEMENT, ON LIPIDS AND C-REACTIVE PROTEIN. A 12-WEEK RANDOMIZED, PLACEBO- CONTROLLED STUDY IN POSTMENOPAUSAL WOMEN Verhoeven M.O., Kenemans P., van der Mooren M.J. (Amsterdam, The Netherlands)
60. A HERBAL REMEDY, FEMAL, MADE FROM POLLEN EXTRACTS, REDUCES HOT 39 FLUSHES AND IMPROVES QUALITY OF LIFE IN MENOPAUSAL WOMEN Rein E., Winther K., Hedman C. (Kolding and Copenhagen, Denmark; Gothenburg, Sweden)
61. CLINICAL EFFICACY AND DRUG SAFETY OF HERBAL REMEDIES IN THE 40 TREATMENT OF CLIMACTERIC COMPLAINTS Briese M., Friede M., Stammwitz U., Henneicke -von Zepelin H.-H., (Rostock and Salzgitter, Germany)
62. THE HERBAL ALTERNATIVES FOR MENOPAUSE STUDY: CHALLENGES IN 40 STUDY DESIGN AND METHOLODOGY Newton K.M., Reed S.D., Grothaus L., Ehrlich K, Guiltinan J., LaCroix A.Z. (Seattle and Kenmore, WA, USA)
36 6 SOYCONTAINING ISOFLAVONES ANDCOGNITIVEFUNCTION;ARANDOMISED 66. SOYCONTAINING ISOFLAVONES ANDPLASMALIPIDS:ARANDOMIZEDDOU- 65. THEEFFECTOFSOYCONTAINING ISOFLAVONES ONBONEMINERALDEN- 64. SOYPHYTOESTROGENSREDUCESPINEBONELOSSINPOSTMENOPAUSAL 63. 7 RESULTS ONPHYTOESTROGENSUSEINTHEMENOPAUSE MANAGEMENT 67. Schouw Y.T. Kreijakamp-Kaspers S.,KokL.,Grobbee D.E.,deHaanE.H.F., AlemanA., DOUBLE-BLIND PLACEBO-CONTROLLEDTRIAL Netherlands) Kreijkamp-Kaspers S.,KokL.,Grobbee D.E., BLE-BLIND PLACEBO-CONTROLLEDTRIAL Netherlands) Kok L.,Kreijkamp-Kaspers S.,Grobbee D.E., SITY INPOSTMENOPAUSAL WOMEN:ADOUBLE-BLINDRANDOMIZEDTRIAL USA) Newton K.M. WOMEN Caputi A.P. , BenvenutiC.,Estronet StudyGroup (MessinaandMonza,Italy) (Utrecht, TheNetherlands) , LaCroix A.Z.,LampeJ.W., LiS.S.,QuP.P., EhrlichK.(Seattle,WA, 37 van derSchouwY.T. van derSchouwY.T. (Utrecht, The (Utrecht, The van der 41 41 41 40 40
SATURDAY FRIDAY THURSDAY WEDNESDAY Palazzo dei Congressi WEDNESDAY, April 21 - SATURDAY, April 24 68-82
POSTER DISPLAY: for the duration of the Symposium (from April 21 to April 24)
POSTER DISCUSSION: one of the authors will be available at the poster on: Thursday April 22 and Friday April 23 from 12.30 pm to 2.00 pm
Poster Session 7 QUALITY OF LIFE, LIFESTYLE AND SOCIO-CULTURAL ASPECTS OF MENOPAUSE
Poster board abstract bk. no.: page ref.:
68. QUALITY OF LIFE ACCORDING TO DIFFERENT MENOPAUSAL STAGES 41 Golian Tehrani S., Mirmohamad A.M., Mahmoodi M., Khaledian Z. (Tehran, Iran)
69. LIFESTYLE AND QUALITY OF LIFE OF MIDDLE-AGED WORKING WOMEN IN 42 SAPPORO, JAPAN Noji A., Hasegawa M., Maruyama T. (Niigata, Kanagawa and Sapporo, Japan)
70. LIFESTYLE OF WOMEN ATTENDING THE MENOPAUSE CLINIC 42 Sarit-apirak S., Manonai J., Udomsubpayakul U., Theppisai U. (Bangkok, Thailand)
71. EFFECTS OF HRT ON QUALITY OF LIFE IN POSTMENOPAUSAL WOMEN WITH 42 POSITIVE MODIFIED ATTITUTE TO MENOPAUSE Cavalli G., Kuciukian S. (Milan, Italy)
72. EFFECT OF HORMONE REPLACEMENT THERAPY ON QUALITY OF LIFE IN 42 POSTMENOPAUSAL AFRICAN AMERICAN WOMEN Pace T.D., Lee L., Engelhardt K., Hathaway D., Ke R., Pruett J. (Memphis, TN, USA)
73. POSTMENOPAUSAL SEXUAL FUNCTION UNDER HORMONAL TREATMENTS- 43 ANDROGENIC AND VASCULAR CORRELATES Ferdeghini F., Nappi R.E., Sampaolo P., Abbiati I., Albani F., Verza A., Salonia A., Montorsi F., Polatti F. (Pavia and Milan, Italy)
74. HORMONE REPLACEMENT THERAPY USE, AMONG GREEK WOMEN, ACCOR- 43 DING TO THEIR SOCIO-ECONOMIC LEVEL Economou A., Panagopoulos P., Kleinaki M., Chontros D., Kannellopoulos N. (Piraneus, Greece)
75. VITAMINS: D, A, E, C STATUS AND BONE MINERAL DENSITY IN HEALTHY 43 POLISH POSTMENOPAUSAL WOMEN Krela-Kazmierczak I., Linke K., Sajdak E., Sajdak S. (Poznan´, Poland)
76. EFFECT OF BODY MASS INDEX (BMI) ON BONE MINERAL DENSITY IN PERI- 43 AND POSTMENOPAUSAL WOMEN Chittacharoen A, Manonai J., Theppisai U. (Bangkok, Thailand)
77. CLINICAL STUDY ON LIFESTYLE RELATED DISEASES MET ON MENOPAUSAL 44 PHYSICIANS WOMEN IN ROMANIA Stuparu E., Marincea E., Ciochirca M.A., Stoenescu M.R. (Bucharest, Romania)
38 2 HYPOACTIVESEXUALDESIREINMENOPAUSAL WOMENINEUROPE 82. PECULIARITIESOFLEAKINGOKNEEOSTEOARTHRITIS INUKRAINIAN PARTICULARITIES THEAGEINGOFWOMENINPOSTMENOPAUSAL PERIOD 81. AGE-RELATED BONELOSSINNORMALPOPULATION OFUKRAINIANWOMEN: 80. ROLEOFBODYIMAGEINMENOPAUSE OFPHYSICIANSWOMENINROMANIA 79. 78. Graziottin A. Povoroznjuk V.V. STRUCTURAL FUNCTIONALSTATE OFBONELOSS WOMEN INPOSTMENOPAUSAL PERIODANDTHECONNECTIONWITH Povoroznjuk V.V. Povoroznjuk V.V. DATA OFULTRASOUND BONEDENSITOMETRY Marincea E. , StuparuE.,Ciochirca M.A.(Bucharest, Romania) , KoochakiP.E. (Milan,ItalyandMason,OH,USA) , GrygoryevaN.V., ZaetsV.B. (Kiev, Ukraine) , GrygoryevaN.V., Dmitrenko O.P. (Kiev, Ukraine) (Kiev, Ukraine) 39 45 45 44 44 44
SATURDAY FRIDAY THURSDAY WEDNESDAY
INDEX OF ABSTRACT CONTRIBUTORS (The number refers to the Abstract Book page)
ABBIATI I. 43 BROMBERGER J.T. 18 DEEV A.D. 30 ABDALLA D.S.P. 38, 39 BROSNAN J.F. 12 DE FRANCISCIS P. 28 ABRAHAMSEN B. 29 BROUCHET L. 3 DE HAAN E.H.F. 41 ADAMI S. 10 BRUSADELLI A. 4 DELAISSÉ J.M. 16 ADEEB N. 13, 33, 34 BURGER H. 11 DELMAS E. 3, 28 ADELWOEHRER N.E. 18 BYSTROVA M.M. 30 DELMAS P.D. 7, 9 AGNUSDEI D. 5 DE MAAT M.P.M. 29 AITTOMAKI K. 30 CAGNACCI A. 3 DENNERSTEIN L. 11, 17, 20 ALBANI F. 43 CAMPOS M.F. 38, 39 DE PASQUALE R. 27 ALDRIGHI J.M. 38, 39 CANNOLETTA M. 3 DI PACE R. 37 ALEMAN A. 41 CAPUTI A.P. 41 DMITRENKO O.P. 44 ALESSANDRINI C. 3 CAPUTO R. 11 DOETSCHMAN T. 3 ALLEN G.O. 24 CARETTO S. 3 DONATI SARTI C. 14 ANDREANI C.L. 21 CARUSO A. 2 DRAGOJEVIC S. 36 APPETECCHIA M. 32 CASTALDO F. 21 DUNCEA I. 34 ARCHER D.F. 24 CATALANO M.G. 24, 31 DUNIC R. 36 ARNAL J.F. 3, 28 CAULEY J.A. 5 DUNJIC R. 30 ATIS A. 28 CAVALLI G. 42 DUNN E. 32 ATSMA F. 12 CHANDA K. 11 DZINIC M. 30, 36 AYDIN Y. 28 CHEPIC O.F. 24 AZCOITIA I. 6 CHITTACHAROEN A. 43 ECONOMOU A. 31, 43 CHONTROS D. 43 EHRLICH K. 6, 35, 40 BAGGIO G. 13 CHRISTENSEN K. 29 EKHOLM O. 21 BAKHIDZE E.V. 24 CHRISTGAU S. 16 ELIADES M. 31 BALDASSARI F. 3 CHRISTIANSEN C. 16 EMEIS J.J. 35 BALMFORTH J. 23 CHRISTOFFEL V. 32 EMRE E. 28 BARBU C. 26 CHRISTOV V. 10 ENGELHARDT K. 42 BARNABEI A. 32 CIANA P. 7 ESTRONET STUDY GROUP 41 BARRETT-CONNOR E. 5 CICUTTINI F. 20 ETTERI S. 19, 20 BARTELINK M.E.L. 12 CIGNARELLA A. 3, 4, 26 BAYARD F. 3, 28 CIOCHIRCA M. 34 FAIT T. 36 BEKESI G. 29 CIOCHIRCA M.A. 27, 34, 44 FALCONE S. 5 BEKTIC J. 32 CIOTTA L. 27, 28, 36 FALCONIER A. 26 BELCREDITO S. 19, 20 CLARENCE K.C.H. 33 FALUDI A.A. 38, 39 BELYAEVA A.V. 24 COLLINS A. 18 FEHER J. 29 BENVENUTI C. 41 COLLINS J. 1 FERDEGHINI F. 43 BERGMANN S. 4 CONARD J. 12 FERNÁNDEZ E. 23 BEROLAMI M.C. 38, 39 COPPI F. 12 FERRELL R. 14 BIGLIA N. 24 CORICA A. 24 FERRETTI E. 32 BIGOZZI M.A. 26 COSTANTINO L. 31 FICA S. 26 BIRKMAYER J. 18 COTSAKOS G. 31 FILIPE C. 28 BLADBJERG E.M. 13 COX D.A. 5 FIORE V. 37 BLAZˇ ÍC´ EK P. 31 COZZARELLA M. 24 FISHMAN D. 22 BOCUZZI G. 24, 31 CRABBE D.L. 21, 29 FORNARI L. 2 BOECK L. 25 CRAVIOTO M.C. 25 FORTUNATI N. 24, 31 BOLEGO C. 3, 4, 26 CRIPPA M. 3 FRAIRIA R. 24, 31 BONNAR J. 12 CROSIGNANI P.G. 37 FRIEDE M. 40 BOTS M.L. 14 CUSHMAN M. 7 BOUXSEIN M.L. 9 CUZZOCREA S. 7 GAMBACCIANI M. 16 BRAMA M. 5 GARCIA-OVEJERO D. 6 BRANDI M.L. 9, 16 DAGUATI R. 37 GARCIA-SEGURA L.M. 6 BRIESE M. 40 D’AMORE M. 25 GARMY-SUSINI B. 3, 28 BRINTON L.A. 13 D’AMORE S. 25 GASS M. 9 BRITOV A.N. 30 DAVIDSEN M. 21 GAVIN K. 2 BRIXEN K. 13, 29 DAY D.S. 4 GAZDAC R. 27 BROCKWELL S. 18 DE BORTOLI M. 23 GEIGER M.J. 5
41 GELFAND M.M. 17 KAKUCS R. 29 MATTHEWS K.M. 18 GENAZZANI A.R. 2, 18 KAMENOV Z. 10 MAXIMOV S.J. 24 GHANI N.A.A. 34 KANNELLOPOULOS N. 43 MCDONNELL D.P. 5 GHEORGHISAN-GALATEANU A. KAPLAN B. 35 MCTIERNAN A. 22 26 KE R. 42 MEIJER P. 12 GHEORMAN V. 27 KEBER I. 30 MENDELSOHN M.E. 1 GHISLETTI S. 19, 20 KENEMANS P. 6, 35, 39 MESCHIA M. 11 · GIANNIOS J. 23 KESIM M.D. 28 MESTANZA-PERALTA M. 25 GOLD E. 18 KHALEDIAN Z. 41 MICHAILAKIS E. 23 GOLIAN TEHRANI S. 41 KLEINAKI M. 31, 43 MIGLIACCIO S. 5 GONZALEZ C. 26 KLOCKER H. 32 MIJATOVIC V. 6, 34, 35 GOURDY P. 3, 28 KLUFT C. 12 MINICI C. 3, 4, 26 GOZANSKY W.S. 4 KOENIG W. 30 MIRKIN S. 24 GOZARIU L. 34 KOHRT W.M. 4 MIRMOHAMAD A. M. 41 GRAM J. 13, 29 KOK H.S. 2 MIX C. 4 GRAZIOTTIN A. 17, 45 KOK L. 40, 41 MODENA M.G. 12 GRIMALDI E. 20 KÖLBL H. 25 MODUGNO F.M. 24 GROBBEE D.E. 2, 12, 14, 40, 41 KOMINDR S. 11 MOHAMED A.L. 13, 34 GROTHAUS L. 6, 35, 40 KOOCHAKI P. 17 MONTORSI F. 43 GRUA D. 10, 20 KOOCHAKI P.E. 45 MORANA M. 27, 28, 36 GRUPPO DI STUDIO PROGETTO KOTARSKI J. 35 MORAWSKA D. 35 MENOPAUSA ITALIA 14 KOWALSKI A.J. 37, 38 MOREAU K.L. 2 GRYGORYEVA N.V. 44, 45 KRAVITZ H. 18 MORESCHINI O. 5 GUASCHINO S. 20 KREIJKAMP-KASPERS S. 40, 41 MORONI S. 37 GUERINI ROCCO A. 20 KRELA-KAZ´ MIERCZAK I. 43 MOSZYNSKI R. 33 GUILTINAN J. 6, 35, 40 KRISTENSEN S.R. 13, 29 MUGNIOT A. 3 GUREVICH B. 10 KUCIUKIAN S. 42 MUSSI P. 7 GUSTAFSSON J.-Å. 14 KULKARNI P.M. 5 GUTHRIE J. 20 NAPPI R.E. 43 GUZˇ ICˇ -SALOBIR B. 30 LA VECCHIA C. 22 NARDI C. 13 LACROIX A.Z. 6, 35, 40 NAWAWI H.M. 13, 34 HAGGERTY C.L. 14 LAITINEN K. 39 NESS R.B. 14, 24 HAKIM A. 26 LAMPE J.W. 40 NETELENBOS J.C. 34 HASEGAWA M. 42 LANDGREN B.M. 11 NEUBERT S. 25 HATHAWAY D. 42 LANZA P. 20 NEWTON K.M. 6, 35, 40 HATTA A.Z. 33 LAURELL H. 28 NG P. 33 HEDMAN C. 39 LEE L. 42 NIKANDER E. 39 HEIJST J.A. 35 LEGAULT C. 19 NIKOLOV I. 10 HELLGREN M. 12 LEKIC D. 36 NINENNA G. 25 HEMMINKI E. 36, 38 LENCU C.C. 34 NOJI A. 42 HENDERSON V.W. 15 LEONI F. 21 NOORAINI M.Y. 13, 34 HENNEICKE-VON ZEPELIN H.-H. LI S.S. 40 NORRIS L.A. 12 40 LIETAVA J. 31 HERMANN A.P. 13 LINDSAY R. 15 OBEL E.B. 21 HERRINGTON D.M. 1 LINDSCHINGER M. 18 O’LEARY J.J. 32 HÖCKERSTEDT A. 29 LINKE K. 43 OLIMID D. 27 HOEGH-ANDERSEN P. 16 LOBO R.A. 5, 8 ONG F.B. 13, 34 HØIDRUP S. 21 LUTJOHANN D. 34 ORBAI P. 34 HONG J.H. 11 ORIGLIANI G. 12 HOUSER S.R. 29 MADSEN J.S. 13, 29 OSSEWAARDE M.E. 14 HOVI S.-L. 36, 38 MAFFIOLETTI C. 37 O’TOOLE S.A. 32 HUNDRUP Y.A. 21 MAGGI A. 4, 7, 19, 20 MAHMOODI M. 41 PACE T.D. 42 ILLYES GY. 29 MAININI G. 28 PANAGOPOULOS P. 31, 43 INGLESE S. 20 MANNELLA P. 2 PARAZZINI F. 14, 37 ISH-SHALOM S. 10 MANOLAGAS S.C. 15 PASZKOWSKI T. 37 ISIK S. 28 MANONAI J. 11, 42, 43 PEARSON P.L. 2 MARINCEA E. 27, 34, 44 PEETERS P.H.M. 2, 14 JAMIL M.A. 26 MARLETTA E. 27, 28, 36 PEREIRA I.R.O. 38, 39 JAUHIAINEN M. 29 MARTIN C. 32 PHAM S.M. 21, 29 JESPERSEN J. 13, 29 MARUYAMA T. 42 PICKAR J.H. 4 JOVANOVIC T. 30 MASSARO R. 32 PIERRO E. 21
42 PIFAROTTI P. 11 SHEPPARD B.L. 32 VAN DER TWEEL I. 2 PINNA C. 3, 26 SHUMAKER S.A. 19 VANPELT R.E. 4 PINSDORF U. 34 SIMONCINI T. 2 VARDUGINA N.G. 31 PIRILLO D. 3 SˇIMUNIC´ V. 17 VARONE G. 2 PLUM A.E. 2 SISMONDI P. 24 VASILJEVIC M. 30, 36 POLATTI F. 43 SITI AISHAH M.A. 33 VEERUS P. 36, 38 POLLOW K. 25 SKOUBY S.O. 3 VEGETO E. 19, 20 POLO-KANTOLA P. 15 SMOLEN A. 33 VEIGA S. 6 POVOROZNJUK V.V. 44, 45 SMYTH P. 32 VERBEEK A.L.M. 14 PRATS A.C. 3 SNOXALL S. 19 VERDEGEM P.J.E. 6 PRATS H. 3 SOMJEN D. 35 VERHOEVEN M.O. 6, 39 PRUETT J. 42 SONGCHITSOMBOON S. 11 VERZA A. 43 PUGLIESE M. 31 SOWERS M. 18 VIRTEJ I. 26 PUGLISI L. 3, 4, 26 SPENGLER B. 32 VLADAREANU R. 25, 26 SPERA G. 5 VOGELVANG T.E. 6, 34, 35 QU P.P. 40 STACHOWICZ N. 35 VOLPE A. 3 QUIRINO L. 28 STAMMWITZ U. 40 VON BERGMAN K. 34 STANEK J. 33 VOROBJOV S. 36 RÂCAˇ N. 27 STEFANICK M.L. 8 VRABLIK M. 36 RAGUSA O.L.F. 10, 20 STEVENSON J. 19 RANDOLPH J. 18 STEVENSON J.C. 16 WEISZ A. 21 RAPP S.R. 19 STOENESCU M.R. 27, 34, 44 WELFEL J. 37, 38 REED S.D. 6, 35, 40 STOJANOVSKA L. 38 WENGER N.K. 12 REIN E. 39 STRUZYCKI K. 37, 38 WHIMS STUDY GROUP 19 REJNMARK L. 13, 29 STUPARU E. 27, 34, 44 WILCOX G. 38 RENZI A. 3 SUCARI A. 26 WILSON P.W.F. 2 RESNICK S.M. 19 SUFIAN S.S. 26 WINTHER K. 39 ROBERTSON D. 11 SUZIN J. 37, 38 WÓJCICKA A. 35 RODENBERG C. 17 SZCZUBLEWSKI P. 33 WONG B.C. 24 ROPPONEN A. 30 SZEKACS B. 29 WONG C.S. 33 ROSIELLO P. 10, 20 SZOEKE C.E.I. 20 WONISCH W. 18 ROSSI M. 37 SZOMBATH D. 29 WUTTKE W. 8, 32 ROSSI R. 12 SZPUREK D. 33 ROSSOUW J.E. 8 YANG J. 21, 29 ROTONDI M. 28 TADJIBAEVA U.T. 33 YLIKORKALA O. 30, 39 TADJIEV H.K. 33 YOLES I. 35 SABIRDJANOVA Z.R. 33 TASIC L. 30, 36 SAJDAK E. 43 TAYIB S. 26 ZAETS V.B. 45 SAJDAK S. 33, 43 TEERLINK T. 6 ZAMBON A. 1 SALONIA A. 43 TEH R. 13 Zˇ EGURA B. 30 SAMPAOLO P. 43 THEPPISAI U. 42, 43 ZHOU M. 3 SÁNCHEZ-GUERRERO J. 25 TIITINEN A. 39 SANVITO P. 26 TIKKANEN M. 30, 39 SARIT-APIRAK S. 42 TIKKANEN M.J. 29 SARTORE A. 20 TODOROVA M. 10 SASHEGYI A. 5 TRIVELLINI C. 21 SCANDURRA R. 5 TSANGALIS D. 38 SCHAFFRATH M. 25 TUTUNARU D. 25 SCHOTT L. 18 SCHWARTZ R.S. 4 UDOMSUBPAYAKUL U. 42 SCOLLO A. 28, 36 UTIAN W.H. 22 SEALS D.R. 2 Sˇ EBESˇ TJEN M. 30 VACHULOVA A. 31 SEGAL E. 10 VAN ASSELT K.M. 2 SEIDLOVA-WUTTKE D. 32 VAN DE WEIJER P.H.M. 6 SERI S.S. 13, 34 VAN DER BURGT L.M.J. 6 SEUFERT R. 25 VAN DER GRAAF Y. 14 SHAH N. 38 VAN DER MOOREN M.J. 2, 6, 34, SHAMSUDDIN K. 13, 34 VAN DER MOOREN M.J. 35, 39 SHARIFAH N.A. 33 VAN DER SCHOUW Y.T. 2, 12, 14, SHEILS O. 32 VAN DER SCHOUW Y.T. 40, 41
43
NOTES NOTES NOTES Finito di stampare nel mese di aprile 2004 presso lalitotipo s.r.l. via Enrico Fermi, 17 - Settimo Milanese (MI) ቢ Palazzo dei Congressi
ባ Railway Station/Air Terminal Lorenzini Foundation Symposium: 298
@http://www.lorenzinifoundation.org